Related Experiment Video
Updated: May 9, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
[How can asthma in children be controlled?]
Sharon Rousso1, David Shoseyov, Eitan Kerem
1Department of Pediatrics, Hadassah-Hebrew University Medical Center, Mount Scopus, Jerusalem, Israel.
Insights
This review covers daily long-term asthma control medications, primarily inhaled corticosteroids (ICS) and leukotriene receptor antagonists, to prevent exacerbations. It also discusses managing severe cases and troubleshooting treatment failures.
Area of Science:
- Pulmonology
- Pharmacology
Context:
- Asthma exacerbations stem from increased airway inflammation.
- Effective management relies on long-term control medications.
Purpose:
- To review daily long-term control medications for preventing asthma exacerbations.
- To outline pharmacotherapy options and management strategies for asthma.
Summary:
- Pharmacotherapy for asthma primarily includes inhaled corticosteroids (ICS) and leukotriene receptor antagonists.
- Severe asthma may require additional treatments like long-acting beta-2 agonists (used with ICS), theophylline, and anti-IgE antibodies.
- A step-up/step-down approach guides controller medication selection. Treatment failure necessitates evaluating adherence, technique, triggers, and diagnosis.
Impact:
- Provides a comprehensive overview of asthma pharmacotherapy.
- Highlights the importance of individualized treatment adjustments and diagnostic confirmation.
Abstract:
Asthma is a disease manifested by recurrent episodes of shortness of breath, wheezing or cough that often require treatment at the emergency department or even hospitalization. These exacerbations are caused by an increased inflammatory process in the airways. This review focuses on the various daily long term control medications used to prevent exacerbations. The pharmacotherapy used to manage asthma is based mainly on inhaled corticosteroids (ICS and leukotriene receptor antagonists. In more severe cases, other drugs can be added, such as long-acting beta 2 agonists lare used only in conjunction with ICS] as well as additional drugs such as slow release theophylline, anti-lgE monoclonal antibodies, and more. The step-up step-down approach is used to decide on the controller medication needed. If the preventive therapy fails, it is essential to assess the adherence to therapy, the technique used, the existence of aggravating factors and the possibility that the cause of the symptoms is not asthma. For proper disclosure the third author (E.K.) has received payment in the past for lectures from Asthma drug companies.
Related Concept Videos
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-I: Introduction
Asthma-IV: Nursing Management
First, in...
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma I: Introduction